Both Semaglutide and Mounjaro represent innovative strategies to addressing type 2 diabetes, and increasingly, weight management. Semaglutide is a combined agonist that works on two receptors involved in metabolism: https://bookmarkyourpage.com/story7737402/grasping-tirzepatide-and-mounjaro-the-detailed-guide